209 related articles for article (PubMed ID: 9676925)
1. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
Davis AR
Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
[No Abstract] [Full Text] [Related]
2. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada.
Armstrong SA; Gangam N; Chipman ML; Rootman DS
Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680
[TBL] [Abstract][Full Text] [Related]
3. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
4. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
5. Impact of donor high-risk social behaviors on recipient survival in cardiac transplantation.
Xu DS; Hartman D; Ludrosky K; Campbell J; Starling RC; Taylor DO; Smedira NG; Gonzalez-Stawinski GV
Transplantation; 2010 Apr; 89(7):873-8. PubMed ID: 20090571
[TBL] [Abstract][Full Text] [Related]
6. [Nosocomial hepatitis B virus, hepatitis C virus and HIV infections by infectious medial personnel].
Hasselhorn HM; Hofmann F
Gesundheitswesen; 1998 Oct; 60(10):545-51. PubMed ID: 9844287
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
8. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
9. Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough?
Sugar J; Mannis M
Cornea; 1997 Mar; 16(2):123-4. PubMed ID: 9071522
[No Abstract] [Full Text] [Related]
10. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
11. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
12. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among eye donors.
Mahalakshmi B; Madhavan HN; Pushpalatha R; Margarita S
Indian J Ophthalmol; 2004 Mar; 52(1):61-2. PubMed ID: 15132383
[TBL] [Abstract][Full Text] [Related]
14. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
15. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
Fasola FA; Kotila TR; Akinyemi JO
Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
[TBL] [Abstract][Full Text] [Related]
16. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
17. HIV, HBV and HCV: new developments related to transfusion safety.
Busch MP
Vox Sang; 2000; 78 Suppl 2():253-6. PubMed ID: 10938963
[No Abstract] [Full Text] [Related]
18. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
Delwart E; Kuhns MC; Busch MP
J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
[TBL] [Abstract][Full Text] [Related]
19. [Amniocentesis and viral risk (hepatitis B, C virus and HIV)].
Ducarme G; Ceccaldi PF; Bernuau J; Luton D
J Gynecol Obstet Biol Reprod (Paris); 2009 Oct; 38(6):469-73. PubMed ID: 19679409
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
Tripathi AK; Khanna M; Gupta N; Chandra M
J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
